Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan

被引：0
|
作者：
Taku Aoki
Norihiro Kokudo
Izumi Komoto
Kyoichi Takaori
Wataru Kimura
Keiji Sano
Takeshi Takamoto
Takuya Hashimoto
Takuji Okusaka
Chigusa Morizane
Tetsuhide Ito
Masayuki Imamura
机构：
[1] The University of Tokyo,Hepato
[2] The University of Tokyo,Biliary
[3] Kansai Electric Power Company Hospital,Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
[4] Kyoto University,Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine
[5] Yamagata University Faculty of Medicine,Department of Surgery
[6] Teikyo University School of Medicine,Department of Hepatobiliary
[7] Japanese Red Cross Medical Center,Pancreatic Surgery and Transplantation, Graduate School of Medicine
[8] National Cancer Center Hospital,Department of Gastroenterological, Breast, Thyroid, and General Surgery
[9] Kyushu University,Department of Surgery
来源：
Journal of Gastroenterology | 2015年 / 50卷
关键词：
Neuroendocrine tumors; Streptozocin; Multi-center survey; Tumor response; Progression-free survival rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：769 / 775
页数：6
相关论文
共 36 条
  • [1] Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan
    Aoki, Taku
    Kokudo, Norihiro
    Komoto, Izumi
    Takaori, Kyoichi
    Kimura, Wataru
    Sano, Keiji
    Takamoto, Takeshi
    Hashimoto, Takuya
    Okusaka, Takuji
    Morizane, Chigusa
    Ito, Tetsuhide
    Imamura, Masayuki
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (07) : 769 - 775
  • [2] Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy
    Shibuya, Hitoshi
    Hijioka, Susumu
    Sakamoto, Yasunari
    Ito, Tetsuhide
    Ueda, Keijiro
    Komoto, Izumi
    Kobayashi, Noritoshi
    Kudo, Atsushi
    Yasuda, Hiroaki
    Miyake, Hayato
    Arita, Junichi
    Kiritani, Sho
    Ikeda, Masafumi
    Imaoka, Hiroshi
    Ueno, Makoto
    Kobayashi, Satoshi
    Furuta, Mitsuhiro
    Nagashio, Yoshikuni
    Murohisa, Gou
    Aoki, Taku
    Matsumoto, Shigemi
    Motoya, Masayo
    Azemoto, Nobuaki
    Itakura, Jun
    Horiguchi, Shigeru
    Yogi, Tatsuji
    Kawagoe, Tetsuro
    Miyaoka, Youichi
    Imamura, Fumito
    Senju, Michio
    Arioka, Hitoshi
    Hara, Kazuo
    Imamura, Masayuki
    Okusaka, Takuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 661 - 668
  • [3] Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy
    Hitoshi Shibuya
    Susumu Hijioka
    Yasunari Sakamoto
    Tetsuhide Ito
    Keijiro Ueda
    Izumi Komoto
    Noritoshi Kobayashi
    Atsushi Kudo
    Hiroaki Yasuda
    Hayato Miyake
    Junichi Arita
    Sho Kiritani
    Masafumi Ikeda
    Hiroshi Imaoka
    Makoto Ueno
    Satoshi Kobayashi
    Mitsuhiro Furuta
    Yoshikuni Nagashio
    Gou Murohisa
    Taku Aoki
    Shigemi Matsumoto
    Masayo Motoya
    Nobuaki Azemoto
    Jun Itakura
    Shigeru Horiguchi
    Tatsuji Yogi
    Tetsuro Kawagoe
    Youichi Miyaoka
    Fumito Imamura
    Michio Senju
    Hitoshi Arioka
    Kazuo Hara
    Masayuki Imamura
    Takuji Okusaka
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 661 - 668
  • [4] Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
    Cheng, Yue-Juan
    Meng, Chang-Ting
    Ying, Hong-Yan
    Zhou, Jian-Feng
    Yan, Xiao-Yan
    Gao, Xin
    Zhou, Na
    Bai, Chun-Mei
    MEDICINE, 2018, 97 (45)
  • [5] The Role of Chemotherapy in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
    Strosberg, Jonathan
    Goldman, Jamie
    Costa, Frederico
    Pavel, Marianne
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 239 - 247
  • [6] Targeted Therapy in Advanced Well-Differentiated Neuroendocrine Tumors
    Raut, Chandrajit P.
    Kulke, Matthew H.
    ONCOLOGIST, 2011, 16 (03) : 286 - 295
  • [7] Evaluation of Streptozocin-Based Chemotherapeutic Regimens for Advanced Pancreatic Neuroendocrine Tumors: A Multi-Center Clinical Study in Japan
    Sakamoto, Y.
    Hijioka, S.
    Shibuya, H.
    Ito, T.
    Imamura, M.
    Komoto, I
    Kobayashi, N.
    Kudo, A.
    Yasuda, H.
    Arita, J.
    Morizane, C.
    Okusaka, T.
    NEUROENDOCRINOLOGY, 2018, 106 : 205 - 205
  • [8] Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
    Strosberg, Jonathan R.
    Fisher, George A.
    Benson, Al B.
    Anthony, Lowell B.
    Arslan, Bulent
    Gibbs, John F.
    Greeno, Edward
    Iyer, Renuka V.
    Kim, Michelle K.
    Maples, William J.
    Philip, Philip A.
    Wolin, Edward M.
    Cherepanov, Dasha
    Broder, Michael S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (08) : 2450 - 2459
  • [9] Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
    Reidy, Diane L.
    Tang, Laura H.
    Saltz, Leonard B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (03): : 143 - 152
  • [10] Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver
    Yang, Zhaohai
    Klimstra, David S.
    Hruban, Ralph H.
    Tang, Laura H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (07) : 915 - 922
1234